Update: 28.10.2025
Last week: 42 week 2025 (13.10.2025 - 19.10.2025)
Last full month: September 2025
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 11 861 | -3.3% | 14.3% | -0.9 | 27 070 592 | -4.1% | 10.5% | -0.9 | 2.9% |
| MoM | 42 067 | 14.7% | 14.1% | 0 | 96 428 888 | 13.5% | 10.6% | -0.1 | 14.8% |
| YTD | 384 135 | 19.2% | 13.4% | 1.4 | 862 262 270 | 30.8% | 10.0% | 0.7 | 6.9% |
| MAT | 483 198 | 20.1% | 13.4% | 1.8 | 1 042 376 005 | 26.4% | 9.9% | 0.7 | 4.2% |
| BRAINMAX | |||||||||
| WoW | 3 826 | 18.6% | 100.0% | 0 | 8 473 336 | 1.1% | 100.0% | 0 | 18.6% |
| MoM | 9 527 | 11.6% | 100.0% | 0 | 32 977 378 | 9.9% | 100.0% | 0 | 11.6% |
| YTD | 98 819 | 73.5% | 100.0% | 0 | 334 355 867 | 67.3% | 100.0% | 0 | 73.5% |
| MAT | 124 519 | 79.4% | 100.0% | 0 | 421 167 538 | 72.5% | 100.0% | 0 | 79.4% |
| GOLDLINE PLUS | |||||||||
| WoW | 13 404 | 1.6% | 45.9% | -1.3 | 44 734 254 | 2.3% | 38.6% | -0.7 | 4.6% |
| MoM | 53 054 | -6.8% | 45.6% | -0.3 | 178 368 619 | -5.5% | 38.0% | 0.3 | -6.3% |
| YTD | 629 497 | -8.3% | 45.8% | 0.7 | 2 048 732 545 | -4.9% | 37.6% | 0.6 | -9.7% |
| MAT | 772 360 | -7.3% | 46.0% | 0.8 | 2 496 657 262 | -4.9% | 37.7% | 0.3 | -8.9% |
| MIGRENIUM | |||||||||
| WoW | 8 233 | -2.7% | 0.3% | 0 | 2 957 051 | -2.5% | 0.5% | 0 | 2.0% |
| MoM | 39 361 | 9.4% | 0.4% | 0 | 14 402 653 | 12.8% | 0.5% | 0.1 | -1.0% |
| YTD | 345 406 | -27.6% | 0.4% | -0.2 | 122 398 723 | -18.6% | 0.5% | -0.2 | 4.5% |
| MAT | 436 038 | -25.5% | 0.4% | -0.1 | 153 629 317 | -11.8% | 0.5% | -0.1 | 2.4% |
| MODELAX-N | |||||||||
| WoW | 27 643 | 3.0% | 19.5% | 0.1 | 16 894 004 | 2.3% | 14.9% | -0.1 | 2.6% |
| MoM | 109 512 | 0.1% | 19.2% | 0.5 | 64 946 198 | 3.2% | 14.5% | 0.5 | -2.2% |
| YTD | 1 159 398 | -2.6% | 19.9% | -2.3 | 635 566 252 | 21.5% | 14.5% | 0.1 | 8.9% |
| MAT | 1 433 086 | -0.3% | 19.9% | -1.6 | 771 839 699 | 26.1% | 14.3% | 0.8 | 7.5% |
| REDUXIN | |||||||||
| WoW | 8 976 | 5.8% | 30.7% | 0.4 | 47 854 421 | 3.6% | 41.3% | -0.2 | 4.6% |
| MoM | 36 948 | -7.8% | 31.8% | -0.5 | 199 239 986 | -9.3% | 42.4% | -1.4 | -6.3% |
| YTD | 434 798 | -12.9% | 31.7% | -1.2 | 2 368 677 222 | -10.6% | 43.4% | -2 | -9.7% |
| MAT | 531 325 | -11.3% | 31.7% | -0.9 | 2 882 587 569 | -8.6% | 43.5% | -1.4 | -8.9% |
| REDUXIN FORTE | |||||||||
| WoW | 3 123 | 5.8% | 10.7% | 0.1 | 15 338 955 | 7.9% | 13.2% | 0.5 | 4.6% |
| MoM | 12 841 | -0.1% | 11.0% | 0.7 | 62 193 604 | 2.0% | 13.2% | 1.1 | -6.3% |
| YTD | 140 217 | 1.6% | 10.2% | 1.1 | 648 812 363 | 9.2% | 11.9% | 1.7 | -9.7% |
| MAT | 169 606 | 1.1% | 10.1% | 1 | 776 564 174 | 7.9% | 11.7% | 1.5 | -8.9% |
| SALVISAR | |||||||||
| WoW | 11 297 | 1.2% | 1.5% | 0 | 6 234 535 | 1.7% | 1.5% | 0 | 0.4% |
| MoM | 50 982 | 19.1% | 1.6% | 0.2 | 27 597 738 | 18.7% | 1.6% | 0.2 | 2.5% |
| YTD | 490 061 | 14.2% | 1.6% | 0.2 | 251 414 832 | 41.9% | 1.6% | 0.4 | -3.0% |
| MAT | 632 746 | 20.9% | 1.7% | 0.4 | 315 172 524 | 51.4% | 1.6% | 0.5 | -4.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 384 135 | 19.2% | 13.4% | 1.4 | 862 262 270 | 30.8% | 10.0% | 0.7 | 6.9% |
| BRAINMAX | 98 819 | 73.5% | 100.0% | 0 | 334 355 867 | 67.3% | 100.0% | 0 | 73.5% |
| GOLDLINE PLUS | 629 497 | -8.3% | 45.8% | 0.7 | 2 048 732 545 | -4.9% | 37.6% | 0.6 | -9.7% |
| MIGRENIUM | 345 406 | -27.6% | 0.4% | -0.2 | 122 398 723 | -18.6% | 0.5% | -0.2 | 4.5% |
| MODELAX-N | 1 159 398 | -2.6% | 19.9% | -2.3 | 635 566 252 | 21.5% | 14.5% | 0.1 | 8.9% |
| REDUXIN CAPS | 434 798 | -12.9% | 31.7% | -1.2 | 2 368 677 222 | -10.6% | 43.4% | -2 | -9.7% |
| REDUXIN FORTE | 140 217 | 1.6% | 10.2% | 1.1 | 648 812 363 | 9.2% | 11.9% | 1.7 | -9.7% |
| SALVISAR | 490 061 | 14.2% | 1.6% | 0.2 | 251 414 832 | 41.9% | 1.6% | 0.4 | -3.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 483 198 | 20.1% | 13.4% | 1.8 | 1 042 376 005 | 26.4% | 9.9% | 0.7 | 4.2% |
| BRAINMAX | 124 519 | 79.4% | 100.0% | 0 | 421 167 538 | 72.5% | 100.0% | 0 | 79.4% |
| GOLDLINE PLUS | 772 360 | -7.3% | 46.0% | 0.8 | 2 496 657 262 | -4.9% | 37.7% | 0.3 | -8.9% |
| MIGRENIUM | 436 038 | -25.5% | 0.4% | -0.1 | 153 629 317 | -11.8% | 0.5% | -0.1 | 2.4% |
| MODELAX-N | 1 433 086 | -0.3% | 19.9% | -1.6 | 771 839 699 | 26.1% | 14.3% | 0.8 | 7.5% |
| REDUXIN CAPS | 531 325 | -11.3% | 31.7% | -0.9 | 2 882 587 569 | -8.6% | 43.5% | -1.4 | -8.9% |
| REDUXIN FORTE | 169 606 | 1.1% | 10.1% | 1 | 776 564 174 | 7.9% | 11.7% | 1.5 | -8.9% |
| SALVISAR | 632 746 | 20.9% | 1.7% | 0.4 | 315 172 524 | 51.4% | 1.6% | 0.5 | -4.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 11 861 | -3.3% | 14.3% | -0.9 | 27 070 592 | -4.1% | 10.5% | -0.9 | 2.9% |
| BRAINMAX | 3 826 | 18.6% | 100.0% | 0 | 8 473 336 | 1.1% | 100.0% | 0 | 18.6% |
| GOLDLINE PLUS | 13 404 | 1.6% | 45.9% | -1.3 | 44 734 254 | 2.3% | 38.6% | -0.7 | 4.6% |
| MIGRENIUM | 8 233 | -2.7% | 0.3% | 0 | 2 957 051 | -2.5% | 0.5% | 0 | 2.0% |
| MODELAX-N | 27 643 | 3.0% | 19.5% | 0.1 | 16 894 004 | 2.3% | 14.9% | -0.1 | 2.6% |
| REDUXIN CAPS | 8 976 | 5.8% | 30.7% | 0.4 | 47 854 421 | 3.6% | 41.3% | -0.2 | 4.6% |
| REDUXIN FORTE | 3 123 | 5.8% | 10.7% | 0.1 | 15 338 955 | 7.9% | 13.2% | 0.5 | 4.6% |
| SALVISAR | 11 297 | 1.2% | 1.5% | 0 | 6 234 535 | 1.7% | 1.5% | 0 | 0.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 42 067 | 14.7% | 14.1% | 0 | 96 428 888 | 13.5% | 10.6% | -0.1 | 14.8% |
| BRAINMAX | 9 527 | 11.6% | 100.0% | 0 | 32 977 378 | 9.9% | 100.0% | 0 | 11.6% |
| GOLDLINE PLUS | 53 054 | -6.8% | 45.6% | -0.3 | 178 368 619 | -5.5% | 38.0% | 0.3 | -6.3% |
| MIGRENIUM | 39 361 | 9.4% | 0.4% | 0 | 14 402 653 | 12.8% | 0.5% | 0.1 | -1.0% |
| MODELAX-N | 109 512 | 0.1% | 19.2% | 0.5 | 64 946 198 | 3.2% | 14.5% | 0.5 | -2.2% |
| REDUXIN CAPS | 36 948 | -7.8% | 31.8% | -0.5 | 199 239 986 | -9.3% | 42.4% | -1.4 | -6.3% |
| REDUXIN FORTE | 12 841 | -0.1% | 11.0% | 0.7 | 62 193 604 | 2.0% | 13.2% | 1.1 | -6.3% |
| SALVISAR | 50 982 | 19.1% | 1.6% | 0.2 | 27 597 738 | 18.7% | 1.6% | 0.2 | 2.5% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N SOL RECTAL USE 12.9 MG/ML+102.6 MG/ML+625 MG/ML 5 ML #20"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N SOL RECTAL USE 12.9 MG/ML+102.6 MG/ML+625 MG/ML 5 ML #20"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs